Chronic lung allograft dysfunction following lung transplantation: challenges and solutions
Bradford C Bemiss, Chad A WittDepartment of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St Louis, MO, USAAbstract: Chronic rejection is a major cause of death after the first year following lung transplantation. Bronchiolitis oblite...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-09-01
|
Series: | Transplant Research and Risk Management |
Online Access: | http://www.dovepress.com/chronic-lung-allograft-dysfunction-following-lung-transplantation-chal-peer-reviewed-article-TRRM |
id |
doaj-f1e21769baeb48c7bc4df4270d225008 |
---|---|
record_format |
Article |
spelling |
doaj-f1e21769baeb48c7bc4df4270d2250082020-11-25T00:23:43ZengDove Medical PressTransplant Research and Risk Management1179-16162014-09-012014default879718516Chronic lung allograft dysfunction following lung transplantation: challenges and solutionsBemiss BCWitt CA Bradford C Bemiss, Chad A WittDepartment of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St Louis, MO, USAAbstract: Chronic rejection is a major cause of death after the first year following lung transplantation. Bronchiolitis obliterans (BO) is the most common pathologic finding on biopsy, characterized by fibrous granulation tissue, which obliterates the lumen of the bronchiole. Clinically, in the absence of tissue for pathology, BO syndrome refers to a progressive irreversible drop in the forced expiratory volume in 1 second. Recently, a broader definition of chronic rejection, termed "chronic lung allograft dysfunction", has been used to encompass a more inclusive definition of posttransplant dysfunction. Recently, the lung transplant community has come to realize that chronic rejection may be the final common result after repetitive epithelial insults. Acute rejection, infection, and alloreactivity to mismatched HLA antigens are a few of these insults that damage the surface of the bronchioles. Recent evidence of autoimmunity to the normally hidden structural proteins collagen V and K-α1 tubulin have been correlated with a BO phenotype as well, perhaps correlating the epithelial damage with a mechanism for developing BO lesions. Many immunomodulatory medications and treatments have been studied for effectiveness for the treatment of chronic lung allograft dysfunction. New drugs, which more precisely target the immune system, are being developed and tested. Further study is required, but recent advances have improved our understanding of the pathogenesis and potential intervention for this common and deadly complication of lung transplantation.Keywords: lung transplant, bronchiolitis obliterans syndrome, rejectionhttp://www.dovepress.com/chronic-lung-allograft-dysfunction-following-lung-transplantation-chal-peer-reviewed-article-TRRM |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Bemiss BC Witt CA |
spellingShingle |
Bemiss BC Witt CA Chronic lung allograft dysfunction following lung transplantation: challenges and solutions Transplant Research and Risk Management |
author_facet |
Bemiss BC Witt CA |
author_sort |
Bemiss BC |
title |
Chronic lung allograft dysfunction following lung transplantation: challenges and solutions |
title_short |
Chronic lung allograft dysfunction following lung transplantation: challenges and solutions |
title_full |
Chronic lung allograft dysfunction following lung transplantation: challenges and solutions |
title_fullStr |
Chronic lung allograft dysfunction following lung transplantation: challenges and solutions |
title_full_unstemmed |
Chronic lung allograft dysfunction following lung transplantation: challenges and solutions |
title_sort |
chronic lung allograft dysfunction following lung transplantation: challenges and solutions |
publisher |
Dove Medical Press |
series |
Transplant Research and Risk Management |
issn |
1179-1616 |
publishDate |
2014-09-01 |
description |
Bradford C Bemiss, Chad A WittDepartment of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St Louis, MO, USAAbstract: Chronic rejection is a major cause of death after the first year following lung transplantation. Bronchiolitis obliterans (BO) is the most common pathologic finding on biopsy, characterized by fibrous granulation tissue, which obliterates the lumen of the bronchiole. Clinically, in the absence of tissue for pathology, BO syndrome refers to a progressive irreversible drop in the forced expiratory volume in 1 second. Recently, a broader definition of chronic rejection, termed "chronic lung allograft dysfunction", has been used to encompass a more inclusive definition of posttransplant dysfunction. Recently, the lung transplant community has come to realize that chronic rejection may be the final common result after repetitive epithelial insults. Acute rejection, infection, and alloreactivity to mismatched HLA antigens are a few of these insults that damage the surface of the bronchioles. Recent evidence of autoimmunity to the normally hidden structural proteins collagen V and K-α1 tubulin have been correlated with a BO phenotype as well, perhaps correlating the epithelial damage with a mechanism for developing BO lesions. Many immunomodulatory medications and treatments have been studied for effectiveness for the treatment of chronic lung allograft dysfunction. New drugs, which more precisely target the immune system, are being developed and tested. Further study is required, but recent advances have improved our understanding of the pathogenesis and potential intervention for this common and deadly complication of lung transplantation.Keywords: lung transplant, bronchiolitis obliterans syndrome, rejection |
url |
http://www.dovepress.com/chronic-lung-allograft-dysfunction-following-lung-transplantation-chal-peer-reviewed-article-TRRM |
work_keys_str_mv |
AT bemissbc chroniclungallograftdysfunctionfollowinglungtransplantationchallengesandsolutions AT wittca chroniclungallograftdysfunctionfollowinglungtransplantationchallengesandsolutions |
_version_ |
1716178033783603200 |